abstract |
The present invention comprises compounds of general formula (1) (see formula 1) wherein A, X, Y, Z, R a, R b, R c, R1, R2 and R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties. |